Abstract
The US state of Montana has become the first in the country to let patients try experimental drugs – even if they are not terminally ill.
The new law allows doctors to refer patients to licensed “experimental treatment centres”, where they can access drugs that have only passed phase 1 clinical trials – the earliest stage of testing in humans.
This goes far beyond existing federal law, which only allows terminally ill patients to access such drugs under the Right to Try Act, passed in 2017.
The new law allows doctors to refer patients to licensed “experimental treatment centres”, where they can access drugs that have only passed phase 1 clinical trials – the earliest stage of testing in humans.
This goes far beyond existing federal law, which only allows terminally ill patients to access such drugs under the Right to Try Act, passed in 2017.
| Original language | English |
|---|---|
| Specialist publication | The Conversation |
| Publisher | The Conversation Trust (UK) Limited |
| Publication status | Published - 6 Jun 2025 |
Keywords
- clinical trials
- Montana
- ethics
- clinical pharmacy